There are 119 resources available
18P - Baseline and dynamic changes in haemoglobin levels predict treatment response and disease progression in metastatic renal cell carcinoma
Presenter: Yu-hsuen Yang
Session: e-Poster Display session
17P - Driving NK cell immunotherapy against NSCLC, in the context of hypoxia, using tri-specific engagers
Presenter: Jeffrey Miller
Session: e-Poster Display session
21P - Transcriptomic mapping of integrins and inmune activation in High- Grade Serous Ovarian Cancer.
Presenter: Katerin Rojas Laimito
Session: e-Poster Display session
16P - Checkpoint modification of BTLA-HVEM-LIGHT signaling by HSV-1 glycoprotein D (gD) improves vaccine-induced CD8+ T cell responses in pre-clinical cancer models
Presenter: Hildegund Ertl
Session: e-Poster Display session
19P - Tumor retargeting universal chimeric antigen receptor T cell (TRUE-CAR T) therapy in solid tumors
Presenter: Fanyan Meng
Session: e-Poster Display session
20P - Immuno-modulating effects of hyperthermia on PD-L1 and NLRC5 in ovarian cancer
Presenter: maha fezza
Session: e-Poster Display session
24P - Evidence for synergy between TNG908, an MTAPnull-selective PRMT5 inhibitor, and sotorasib in an MTAPnull/KRASG12C xenograft model
Presenter: KIMBERLY BRIGGS
Session: e-Poster Display session
28P - Discovery of Potent PROTAC Degraders of KRASG12C Based on a Reversible Non-covalent KRAS Binder
Presenter: Zhimin Zhang
Session: e-Poster Display session
14P - A novel small molecule METTL3 inhibitor exerts promising antitumor effects on oral squamous cell carcinoma
Presenter: Paramasivam Arumugam
Session: e-Poster Display session
9P - Preliminary population pharmacokinetic (popPK) co-variates and exposure response (ER) assessment of QT for RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase
Presenter: Elizabeth Lee
Session: e-Poster Display session